Scarica l'app Stockscreener
1.51
6.21%
-0.10
Dopo l'orario di chiusura:
1.51
Fractyl Health Inc Borsa (GUTS) Ultime notizie
Fractyl Health (NASDAQ:GUTS) Price Target Cut to $10.00 by Analysts at Morgan Stanley - MarketBeat
Fractyl Health, Inc. (NASDAQ:GUTS) CEO Harith Rajagopalan Sells 90,972 Shares - MarketBeat
Potential Price Increase for Fractyl Health Inc (GUTS) After Recent Insider Activity - Knox Daily
BlackRock, Inc. Increases Stake in Fractyl Health Inc: A Strategic Move in Biotechnology - GuruFocus.com
Fractyl Health, Inc. (NASDAQ:GUTS) Stock Position Lifted by JPMorgan Chase & Co. - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Insider Jay David Caplan Sells 22,346 Shares - MarketBeat
Fractyl Health Inc (GUTS) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Trading Day Triumph: Fractyl Health Inc (GUTS) Ends at 1.70, a -7.61 Surge/Plunge - The Dwinnex
Fractyl Health (NASDAQ:GUTS) Given New $10.00 Price Target at Morgan Stanley - Defense World
Fractyl Health announces layoffs as it pivots to gene therapy - Mass Device
Burlington biotech company announces layoffs, pivots research focus - NBC Boston
Fractyl Health Announces Increased Focus on Groundbreaking - GlobeNewswire
Fractyl Health pivots Type 2 diabetes device therapy toward obesity and GLP-1s, lays off 17% of staff - Fierce Biotech
Fractyl Health announces increased focus on Revita, Rejuva programs - TipRanks
Fractyl Health Reprioritizes Focus on REMAIN-1 Study - TipRanks
Weight Loss Breakthrough: Fractyl's Post-GLP-1 Maintenance Program Shows Promise as Company Pivots Strategy - StockTitan
Burlington biotech slims down 17% of workforce, focuses on weight maintenance treatment - The Business Journals
Barclays PLC Grows Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Large Growth in Short Interest - MarketBeat
Head-To-Head Analysis: Tactile Systems Technology (NASDAQ:TCMD) and Fractyl Health (NASDAQ:GUTS) - Defense World
Fractyl Health’s Promising Progress in Weight Management - TipRanks
Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort - The Manila Times
Fractyl Health Announces Positive Initial Clinical Results - GlobeNewswire
Fractyl Health Reports Breakthrough: Patient Maintains 15% Weight Loss After GLP-1 Discontinuation - StockTitan
Geode Capital Management LLC Has $1.27 Million Stock Position in Fractyl Health, Inc. (NASDAQ:GUTS) - MarketBeat
Geode Capital Management LLC Acquires 313,335 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Barclays PLC Has $121,000 Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Here’s Why Fractyl Health, Inc. (NASDAQ:GUTS) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
State Street Corp Purchases 63,968 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
HighTower Advisors LLC Takes $38,000 Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
BNP Paribas Financial Markets Increases Stake in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Charles Schwab Investment Management Inc. Has $204,000 Stock Position in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Critical Contrast: Fractyl Health (GUTS) and Its Rivals - Defense World
GUTSFractyl Health, Inc. Latest Stock News & Market Updates - StockTitan
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva® Smart GLP-1™ Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRD - GlobeNewswire
Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local - The Bakersfield Californian
Fractyl Health's GLP-1 Gene Therapy Shows Breakthrough Results in Preclinical Study5x Higher Expression - StockTitan
Fractyl Health to Present New Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) - The Manila Times
Fractyl Health to Present Breakthrough GLP-1 Gene Therapy Data for Diabetes Treatment at WCIRDC 2024 - StockTitan
Is Fractyl Health (NASDAQ:GUTS) Using Debt Sensibly? - Simply Wall St
Analysts Update Their Estimates For Alpha Teknova Inc - Stocks Register
Pulmonx (NASDAQ:LUNG) vs. Fractyl Health (NASDAQ:GUTS) Head-To-Head Review - Defense World
Fractyl Health to Participate in the Upcoming December Conferences - GlobeNewswire
Fractyl Health CEO to Present at Evercore, Piper Sandler Healthcare Conferences - StockTitan
Fractyl Health Stock Price Prediction: 2024, 2025, 2030 - Benzinga
Why This Penny Stock Lost 13% Last Week While Markets Soared - MSN
Comparing Fractyl Health (GUTS) and Its Rivals - Defense World
Comparing Fractyl Health (GUTS) and Its Peers - Defense World
Head to Head Analysis: Fractyl Health (GUTS) versus Its Peers - Defense World
Fractyl Health management to meet virtually with B. Riley - Nasdaq
Lee Ainslie's Strategic Reduction in Fractyl Health Inc Holdings - GuruFocus.com
Fractyl Health president sells $158,540 in stock By Investing.com - Investing.com Australia
Fractyl Health president sells $158,540 in stock - Investing.com India
Fractyl Health Third Quarter 2024 Earnings: US$0.48 loss per share (vs US$9.61 loss in 3Q 2023) - Yahoo Finance
Fractyl Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):